Furthermore, a strong association between elevated PTX3 expression and higher serum alpha fetoprotein (AFP) levels, larger tumor size, and more advanced tumor stages suggests that PTX3 could serve as a prognostic biomarker for HCC (97). This evidence concerns the gene PTX3 and neoplasm.